Verified July 2026 · Cited to primary sources
BPC-157: Evidence Grade D. Animal studies only, unproven in humans.
The most-hyped, least-human-proven "healing" peptide. Extensive rodent data, zero published human trials.
The honest verdict
BPC-157 is not FDA-approved and is not yet legal to compound. On July 23, 2026 the FDA's PCAC panel voted 8 to 6 (1 abstention) to recommend adding it to the 503A list for ulcerative colitis, overriding the FDA's own scientists, but that is a recommendation only and the FDA has not decided. Human evidence stays Grade D: animal studies only. If you pursue it, wait for the FDA's ruling and use a licensed provider, never gray-market vials.
BPC-157 at a glance
- Class
- Synthetic pentadecapeptide (15-aa partial sequence of a protein in human gastric juice)
- Mechanism
- Promotes angiogenesis and tissue repair by upregulating growth-factor/VEGF and nitric-oxide pathways. Marketed as a "healing" peptide for gut, tendon and muscle injury, but that use is experimental.
- Also known as
- Body Protection Compound-157, PL 14736, BPC-157 acetate
- Research applications
- Tendon, ligament and muscle injury recovery (preclinical)
- Gut/IBD-type inflammation (ulcerative colitis is the PCAC-evaluated indication)
- Forms
- subcutaneous injection, oral capsule
- Legal status
- Under FDA review
- WADA (anti-doping)
- Prohibited (S0, non-approved substances) at all times
- Evidence grade
- Grade DAnimal studies only, unproven in humans
How we grade evidence
Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is BPC-157?
Compound class: Synthetic pentadecapeptide (15-aa partial sequence of a protein in human gastric juice)
Promotes angiogenesis and tissue repair by upregulating growth-factor/VEGF and nitric-oxide pathways. Marketed as a "healing" peptide for gut, tendon and muscle injury, but that use is experimental.
How strong is the evidence for BPC-157?
Grade D: only animal/preclinical evidence, no published human efficacy RCT (decision-tree rule 5 fired). The Sikirić rodent literature is extensive, but none of it has been replicated in a controlled human trial.
Primary sources (4)
Is BPC-157 legal? (Status July 2026)
Regulatory limbo; the July 2026 PCAC panel has advised, the FDA decision is pending.
July 2026 PCAC vote
On July 23, 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 to the 503A compounding list (8 to 6, with 1 abstention), overriding the FDA's own scientists. That is an advisory recommendation, not legalization: the FDA still makes the final decision and has not acted, so BPC-157 is not yet legally compoundable. Track the FDA peptide vote →
What is BPC-157 used for?
BPC-157 is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.
What does BPC-157 cost, and how do you access it legally?
Typical cost
$350 to $900 (clinic-supervised course)
Clinic-supervised course pricing per peakedlabs.com/blog/bpc-157-cost-guide-2026. We don't quote gray-market vial pricing on purpose.
No legal supervised access route right now.
BPC-157 has no compliant US route today while its compounding status is under FDA review. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole, so we don't link them. If you pursue BPC-157, do it with a licensed clinician, and re-check its legal status first.
Telehealth programs do advertise several compounds in this position as prescribable online. We checked those advertised menus against the law in peptide telehealth programs.
Is BPC-157safe? Side effects & risks
No human safety data. Theoretical tumor/angiogenesis concern given its growth-factor mechanism. Heavy gray-market contamination; long-term safety unknown. WADA-prohibited (S0) at all times.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
Free tool
Peptide reconstitution calculator
Enter the mg in the vial and the ml of bacteriostatic water, and get the concentration plus the units to draw on an insulin syringe. It does the arithmetic on your numbers, and it never suggests a dose. See all four calculators.
FAQ
BPC-157 FAQ
Is BPC-157 FDA approved?
No. BPC-157 is not FDA-approved for any indication. It was removed from the 503A Category 2 list in April 2026, and on July 23, 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6 (1 abstention) to recommend adding it to the 503A compounding list for ulcerative colitis. That recommendation is advisory; the FDA still makes the final call and has not yet acted.
Does BPC-157 actually work?
The healing claims come almost entirely from rodent studies. There are no published human efficacy trials, so on our scale BPC-157 is Grade D: animal studies only, unproven in humans. The July 2026 PCAC vote was about a legal compounding route, not about whether it works.
Is BPC-157 legal to buy now that PCAC voted for it?
Not yet. The July 23, 2026 PCAC vote was a recommendation to the FDA, not a legalization. Until the FDA acts on that recommendation, there is no legal, supervised US route to BPC-157. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole.
Is BPC-157 banned in sport?
Yes. BPC-157 is on the WADA Prohibited List under S0 (non-approved substances), banned at all times for tested athletes.
From our portfolio
Tracking BPC-157?
Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.
Compare BPC-157 with…
Head-to-head evidence-grade matchups people weigh against BPC-157.
Keep reading
TB-500
The other half of the "wolverine stack." Soft-tissue recovery claims, but only animal data for the fragment actually sold.
Grade DKPV
An anti-inflammatory tripeptide studied for gut and skin inflammation. Promising in cells and animals, untested in humans.
Grade BSermorelin
The "gentler," formerly-FDA-approved GH-axis peptide. It's the best-evidenced option you can still legally get through a compounding pharmacy.
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.